Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ri Han

Showing results (141-150 of 146) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 146 results.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|December 13, 2019
Hemistepsin A alleviates liver fibrosis by inducing apoptosis of activated hepatic stellate cells via inhibition of nuclear factor-κB and AktJae Kwang Kim, Nu Ri Han, Sang Mi Park, et al.
Annals of Translational Medicine|June 24, 2021
Matched pair analysis for comparison of survival outcome of alternative regimens to standard three-weekly cisplatin-based concurrent chemoradiation of head and neck cancerHye Ri Han, Sung Jun Ma, Gregory M Hermann, et al.
Annals of Translational Medicine|June 24, 2021
Matched pair analysis to evaluate weight loss during radiation therapy for head and neck cancer as a prognostic factor for survivalHye Ri Han, Gregory M Hermann, Sung Jun Ma, et al.
Oral Oncology|June 20, 2020
Matched pair analysis to evaluate the impact of hospitalization during radiation therapy as an early marker of survival in head and neck cancer patientsHye Ri Han, Gregory M Hermann, Sung Jun Ma, et al.
Molecular Cancer|April 14, 2025
KF1601, a dual inhibitor of BCR::ABL1 and FLT3, overcomes drug resistance in FLT3<sup>+</sup> blast phase chronic myeloid leukemiaHyun-Jin Kwon, Ji Eun Shin, Amir Khan, et al.
Rheumatology (Oxford, England)|November 24, 2020
Efficacy, pharmacokinetics and safety of subcutaneous versus intravenous CT-P13 in rheumatoid arthritis: a randomized phase I/III trialRene Westhovens, Piotr Wiland, Marek Zawadzki, et al.
Pageof 15

Showing results (141-150 of 146) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 146 results.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|December 13, 2019
Hemistepsin A alleviates liver fibrosis by inducing apoptosis of activated hepatic stellate cells via inhibition of nuclear factor-κB and AktJae Kwang Kim, Nu Ri Han, Sang Mi Park, et al.
Annals of Translational Medicine|June 24, 2021
Matched pair analysis for comparison of survival outcome of alternative regimens to standard three-weekly cisplatin-based concurrent chemoradiation of head and neck cancerHye Ri Han, Sung Jun Ma, Gregory M Hermann, et al.
Annals of Translational Medicine|June 24, 2021
Matched pair analysis to evaluate weight loss during radiation therapy for head and neck cancer as a prognostic factor for survivalHye Ri Han, Gregory M Hermann, Sung Jun Ma, et al.
Oral Oncology|June 20, 2020
Matched pair analysis to evaluate the impact of hospitalization during radiation therapy as an early marker of survival in head and neck cancer patientsHye Ri Han, Gregory M Hermann, Sung Jun Ma, et al.
Molecular Cancer|April 14, 2025
KF1601, a dual inhibitor of BCR::ABL1 and FLT3, overcomes drug resistance in FLT3<sup>+</sup> blast phase chronic myeloid leukemiaHyun-Jin Kwon, Ji Eun Shin, Amir Khan, et al.
Rheumatology (Oxford, England)|November 24, 2020
Efficacy, pharmacokinetics and safety of subcutaneous versus intravenous CT-P13 in rheumatoid arthritis: a randomized phase I/III trialRene Westhovens, Piotr Wiland, Marek Zawadzki, et al.
Pageof 15